Coinjection with CAFs resulted in a reduced response to chemotherapy, with larger tumor sizes and weights and an increased proliferation rate in tumor cells evaluated by Ki-67 assay (Fig. 3J-K, Fig. S4D-F). This evidence concerns the gene MKI67 and neoplasm.